Journal Club
| Name | INFECTIOUS DISEASES INSTITUTE |
|---|---|
| Activity Title | Journal Club |
| Details | Phase 3 Trial of Weekly Oral Islatravir–Lenacapavir for HIV-1 Treatment |
| Competence | General Medicine |
| Start Date | 10-08-2026 |
| End Date | 10-08-2026 |
| Event Time | 08:00 AM |
| Location | Hybrid ( Virtual and Training Rooms Mulago) |
| Cost (UGX) | 0 |
| CPD Points | 1 |